QDEL — Quidelortho Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapContrarian

Annual income statement for Quidelortho, fiscal year end - December 29th, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2023 December 31st	2023 January 1st	2024 December 29th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,662	1,699	2,998	3,266	2,783
Cost of Revenue
Gross Profit	1,349	1,271	1,494	1,936	1,287
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	612	792	2,859	2,446	4,744
Operating Profit	1,050	906	139	820	-1,961
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,040	900	-29.1	736	-2,132
Provision for Income Taxes
Net Income After Taxes	810	704	-10.1	549	-2,052
Net Income Before Extraordinary Items
Net Income	810	704	-10.1	549	-2,052
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	811	704	-10.1	549	-2,052
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	18.9	16.6	1.14	11.7	-10.9